Effects of salicylic acid on basal and amphetamine-induced striatal dop amine release

A microdialysis study

T. H. Wu, I. N. Acwonh, T. J. Mäher

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Salicylic acid (SA) is currently employed by many investigators as a tool to investigate hydroxyl free radical formation in in vivo systems via the quantitation of the SA products 2,3-dihydroxybenzoic acid (DHBA) and 2,5-DHBA We investigated the effects of SA on basal and damphetamine (AMP) induced striatal dopamine (DA) release using in vivo microdialysis. After a 3 mm loop-design microdialysis probe was stereotaxically implanted into the striatum of urethane-anesthetized rats, and following 2 hrs stabilization, 3 basal dialysates were collected. SA (0, 30, 100, 300 mg/kg, i.p.) was then administered followed 30 min later by AMP (5 mg/kg, i p.). With the exception of the highest dose of SA, no changes in DA were observed prior to AMP administration SA (300 mg/kg) significantly increased DA levels at 30 min (49%) prior to AMP administration. AMP increased DA by 40-57 fold in all groups of animals. SA in any dose failed to significantly alter the increase in DA levels in response to AMP at 30 or 45 min These results demonstrate the ability of SA to modify basal DA levels, but only at high doses, while having no effect on AMP-stimulated release.

Original languageEnglish
JournalFASEB Journal
Volume10
Issue number3
Publication statusPublished - 1996
Externally publishedYes

Fingerprint

amphetamine
Corpus Striatum
Salicylic Acid
Microdialysis
Amphetamine
amines
salicylic acid
Adenosine Monophosphate
Amines
dopamine
Dopamine
dosage
urethane
microdialysis
acids
Urethane
Dialysis Solutions
Hydroxyl Radical
probes (equipment)
Free Radicals

ASJC Scopus subject areas

  • Agricultural and Biological Sciences (miscellaneous)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Biochemistry
  • Cell Biology

Cite this

Effects of salicylic acid on basal and amphetamine-induced striatal dop amine release : A microdialysis study. / Wu, T. H.; Acwonh, I. N.; Mäher, T. J.

In: FASEB Journal, Vol. 10, No. 3, 1996.

Research output: Contribution to journalArticle

@article{35a927315e2b4da1856072520e8f8a01,
title = "Effects of salicylic acid on basal and amphetamine-induced striatal dop amine release: A microdialysis study",
abstract = "Salicylic acid (SA) is currently employed by many investigators as a tool to investigate hydroxyl free radical formation in in vivo systems via the quantitation of the SA products 2,3-dihydroxybenzoic acid (DHBA) and 2,5-DHBA We investigated the effects of SA on basal and damphetamine (AMP) induced striatal dopamine (DA) release using in vivo microdialysis. After a 3 mm loop-design microdialysis probe was stereotaxically implanted into the striatum of urethane-anesthetized rats, and following 2 hrs stabilization, 3 basal dialysates were collected. SA (0, 30, 100, 300 mg/kg, i.p.) was then administered followed 30 min later by AMP (5 mg/kg, i p.). With the exception of the highest dose of SA, no changes in DA were observed prior to AMP administration SA (300 mg/kg) significantly increased DA levels at 30 min (49{\%}) prior to AMP administration. AMP increased DA by 40-57 fold in all groups of animals. SA in any dose failed to significantly alter the increase in DA levels in response to AMP at 30 or 45 min These results demonstrate the ability of SA to modify basal DA levels, but only at high doses, while having no effect on AMP-stimulated release.",
author = "Wu, {T. H.} and Acwonh, {I. N.} and M{\"a}her, {T. J.}",
year = "1996",
language = "English",
volume = "10",
journal = "FASEB Journal",
issn = "0892-6638",
publisher = "FASEB",
number = "3",

}

TY - JOUR

T1 - Effects of salicylic acid on basal and amphetamine-induced striatal dop amine release

T2 - A microdialysis study

AU - Wu, T. H.

AU - Acwonh, I. N.

AU - Mäher, T. J.

PY - 1996

Y1 - 1996

N2 - Salicylic acid (SA) is currently employed by many investigators as a tool to investigate hydroxyl free radical formation in in vivo systems via the quantitation of the SA products 2,3-dihydroxybenzoic acid (DHBA) and 2,5-DHBA We investigated the effects of SA on basal and damphetamine (AMP) induced striatal dopamine (DA) release using in vivo microdialysis. After a 3 mm loop-design microdialysis probe was stereotaxically implanted into the striatum of urethane-anesthetized rats, and following 2 hrs stabilization, 3 basal dialysates were collected. SA (0, 30, 100, 300 mg/kg, i.p.) was then administered followed 30 min later by AMP (5 mg/kg, i p.). With the exception of the highest dose of SA, no changes in DA were observed prior to AMP administration SA (300 mg/kg) significantly increased DA levels at 30 min (49%) prior to AMP administration. AMP increased DA by 40-57 fold in all groups of animals. SA in any dose failed to significantly alter the increase in DA levels in response to AMP at 30 or 45 min These results demonstrate the ability of SA to modify basal DA levels, but only at high doses, while having no effect on AMP-stimulated release.

AB - Salicylic acid (SA) is currently employed by many investigators as a tool to investigate hydroxyl free radical formation in in vivo systems via the quantitation of the SA products 2,3-dihydroxybenzoic acid (DHBA) and 2,5-DHBA We investigated the effects of SA on basal and damphetamine (AMP) induced striatal dopamine (DA) release using in vivo microdialysis. After a 3 mm loop-design microdialysis probe was stereotaxically implanted into the striatum of urethane-anesthetized rats, and following 2 hrs stabilization, 3 basal dialysates were collected. SA (0, 30, 100, 300 mg/kg, i.p.) was then administered followed 30 min later by AMP (5 mg/kg, i p.). With the exception of the highest dose of SA, no changes in DA were observed prior to AMP administration SA (300 mg/kg) significantly increased DA levels at 30 min (49%) prior to AMP administration. AMP increased DA by 40-57 fold in all groups of animals. SA in any dose failed to significantly alter the increase in DA levels in response to AMP at 30 or 45 min These results demonstrate the ability of SA to modify basal DA levels, but only at high doses, while having no effect on AMP-stimulated release.

UR - http://www.scopus.com/inward/record.url?scp=4243822579&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=4243822579&partnerID=8YFLogxK

M3 - Article

VL - 10

JO - FASEB Journal

JF - FASEB Journal

SN - 0892-6638

IS - 3

ER -